Fortrea Holdings Inc. (FTRE) Financial Statements
Industry: Medical Laboratories (Services)
In fiscal 2025, Fortrea reported revenue of $2.72B, up 1.0% from $2.70B the year before. Net income was -$986.2M (a -36.2% net margin), or -$10.81 per diluted share. Gross margin was -32.0% and operating margin was -32.0%. Operating activities generated $113.5M of cash, leaving $88.3M of free cash flow. At fiscal year end, Fortrea held $2.72B in total assets against $2.15B in total liabilities, including $174.6M of cash and equivalents.
Open the full interactive Fortrea financials → Quarterly statements, key ratios, valuation history and price charts.
Fortrea Key Stats
| Share Price | $20.92 |
|---|---|
| Market Cap | $1.98B |
| Revenue YoY Growth | +1.0% |
| 52-Week Range | $8.87 – $21.11 |
| Shares Outstanding | 94.8 million (basic, 2026 Q2) |
Fortrea Income Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Revenue | $3.11B | $2.70B | $2.72B |
| Cost of Goods Sold | $3.05B | $2.86B | $3.60B |
| Gross Profit | $63.1M | -$161.9M | -$872.6M |
| Operating Income | $63.1M | -$161.9M | -$872.6M |
| Pre-Tax Income | $1.1M | -$275.0M | -$983.0M |
| Income Tax | $4.5M | -$3.5M | $3.2M |
| Net Income | -$3.4M | -$328.5M | -$986.2M |
| Diluted EPS | -$0.04 | -$3.67 | -$10.81 |
Fortrea Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $701.3M | $660.5M | $636.5M | $678.2M |
| Net Income | -$15.9M | -$32.5M | -$23.6M | -$13.2M |
| Diluted EPS | -$0.17 | — | -$0.25 | -$0.14 |
Fortrea Balance Sheet
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash & Equivalents | $108.6M | $118.5M | $174.6M |
| Current Assets | $1.25B | $948.2M | $897.2M |
| Total Assets | $4.36B | $3.58B | $2.72B |
| Current Liabilities | $775.9M | $949.5M | $913.3M |
| Total Long-Term Debt | $1.59B | $1.12B | $1.05B |
| Total Liabilities | $2.62B | $2.22B | $2.15B |
| Shareholders' Equity | $1.74B | $1.36B | $563.5M |
Fortrea Cash Flow Statement
| FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|
| Cash From Operations | $167.4M | $262.8M | $113.5M |
| Cash From Investing | -$31.8M | $251.6M | $14.4M |
| Cash From Financing | -$139.0M | -$497.8M | -$76.3M |
| Free Cash Flow | $127.1M | $237.3M | $88.3M |
Figures from Fortrea's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Fortrea financials page for every line item.
Fortrea Company Profile
| Ticker | FTRE |
|---|---|
| Exchange | Nasdaq |
| Industry | Medical Laboratories (Services) |
| Headquarters | Durham, North Carolina |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001965040 |
Frequently Asked Questions
What was Fortrea's revenue in fiscal 2025?
Fortrea (FTRE) reported revenue of $2.72B for fiscal 2025.
What is Fortrea's annual revenue history?
Fortrea's annual revenue by fiscal year: 2023: $3.11B; 2024: $2.70B; 2025: $2.72B.
What was Fortrea's net income in fiscal 2025?
Fortrea reported net income of -$986.2M for fiscal 2025.
What was Fortrea's earnings per share (EPS) in fiscal 2025?
Fortrea's diluted EPS was -$10.81 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Fortrea generate in fiscal 2025?
Fortrea generated $88.3M of free cash flow in fiscal 2025.
What was Fortrea's revenue last quarter?
In its most recent reported quarter (2026 Q2), Fortrea reported revenue of $678.2M.
How much debt does Fortrea have?
Fortrea reported $1.05B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Fortrea are outstanding?
Fortrea reported a weighted average of 94.8 million basic shares outstanding in 2026 Q2.
What is Fortrea's market cap?
Based on its latest closing price, Fortrea (FTRE) has a market capitalization of about $1.98B.
When does Fortrea's fiscal year end?
Fortrea's fiscal year end, as registered with the SEC, is December 31.
Where is Fortrea headquartered?
Fortrea lists its business address in Durham, North Carolina in its SEC filings.